Biogen to Present at Bernstein’s 31st Annual Strategic Decisions Conference
Get Alerts BIIB Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) announced today that it will present at Bernstein’s 31st Annual Strategic Decisions Conference. The webcast will be live on Wednesday, May 27, 2015 at 2:00 p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com. An archived version of the webcast will be available for 14 days following the presentation.
About Biogen
Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For product labeling, press releases and additional information about the company, please visit www.biogen.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150520005683/en/
Biogen
Karen Jewell, 781-464-2442
Investor Relations
Source: Biogen Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) tops earnings expectations but revenue falls short
- WNS Announces Fiscal 2024 Fourth Quarter and Full Year Earnings, Provides Guidance for Fiscal 2025
- FTAI Aviation Ltd. and LATAM Airlines Group S.A. Engineer Perpetual Power Program
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!